New York State Common Retirement Fund’s Neos Therapeutics, Inc NEOS Stock Holding History

New York State Common Retirement Fund’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-24,100	Closed	-$63K	–	3336
2019 Q1	$63K	Hold	24,100	–	–	﹤0.01%	3042
2018 Q4	$40K	Hold	24,100	–	–	﹤0.01%	3112
2018 Q3	$117K	Hold	24,100	–	–	﹤0.01%	3023
2018 Q2	$151K	Hold	24,100	–	–	﹤0.01%	2997
2018 Q1	$200K	Buy	24,100 +6,700	+39%	+$64K	﹤0.01%	2729
2017 Q4	$177K	Hold	17,400	–	–	﹤0.01%	2810
2017 Q3	$159K	Buy	17,400 +7,000	+67%	+$53.2K	﹤0.01%	2887
2017 Q2	$76K	Sell	10,400 -1	-0%	-$8	﹤0.01%	3122
2017 Q1	$75K	Buy	10,401 +1	+0%	+$6	﹤0.01%	3016
2016 Q4	$61K	Hold	10,400	–	–	﹤0.01%	3039
2016 Q3	$68K	Hold	10,400	–	–	﹤0.01%	3050
2016 Q2	$97K	Buy	10,400 +6,700	+181%	+$63.9K	﹤0.01%	3002
2016 Q1	$40K	Hold	3,700	–	–	﹤0.01%	3089
2015 Q4	$53K	Buy	+3,700	New	+$55.8K	﹤0.01%	3107

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's NEOS Position: Q2 2019 in Review

New York State Common Retirement Fund sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 24,100 shares — an estimated $63K sold.

New York State Common Retirement Fund first reported a position in NEOS in Q4 2015 and held it in 14 quarters. The position peaked at $200K in Q1 2018. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

New York State Common Retirement Fund reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
New York State Common Retirement Fund sold 24,100 Neos Therapeutics, Inc shares in Q2 2019, an estimated $63K.
New York State Common Retirement Fund first reported a position in Neos Therapeutics, Inc in Q4 2015 and held it in 14 quarters.
New York State Common Retirement Fund's Neos Therapeutics, Inc position peaked at $200K in Q1 2018.
58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on New York State Common Retirement Fund's 13F filing for Q2 2019, filed 9 Aug 2019.